FBIO
Fortress Biotech, Inc.
Biotechnology · Healthcare · United States
2.00
close · 2026-10-29
value
98
cheaper than peers98
quality
70
stronger fundamentals70
ranked against
Biotechnology (commercial)
value
quality
161 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 1.42× | 96 |
| price to book | 0.41× | 95 |
| EV to EBITDA | 0.29× | 86 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 116.0% | 99 |
| operating margin | -53.5% | 61 |
| revenue growth | 14.0% | 45 |
| debt to equity | 25.9% | 41 |
4 of 4 measures available
Facts
| market cap | $67M |
| free cash flow | -$16.9M |
| employees | 78 |
| first trade | 2011-11-17 |
| next earnings | not reported |
| fundamentals updated | 2026-08-18 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.07 | -2.69 | -8.47 | -14.55 |
| free cash flow | -$65.8M | -$95.2M | -$136.3M | -$182.5M |
| net income | $6.8M | -$46.0M | -$60.6M | -$86.6M |
| revenue | $63.3M | $57.7M | $84.5M | $75.7M |
| unusual items | $26.7M | $223,000 | $1.3M | $1.1M |